Ursula Wimmer is a highly experienced professional in quality assurance and regulatory compliance within the biotechnology and pharmaceutical sectors, currently serving as the Quality Lead for Individualized Neoantigen Specific Immunotherapy in Cell and Gene Therapy Quality at Roche since January 2010. With a Ph.D. in Molecular Biology from the University of Zurich, Ursula has extensive expertise in developing quality strategies, leading cross-functional teams, and managing compliance for innovative gene therapies and biologics. Previous roles include Principal Quality Assurance Manager, where Ursula was instrumental in establishing quality management strategies for contract manufacturing organizations, and multiple senior management positions overseeing quality assurance across various drug product manufacturing processes. Ursula’s contributions to Roche include leading capability assessments, ensuring adherence to international regulations, and driving quality performance in collaboration with global partners.
This person is not in the org chart
This person is not in any teams
This person is not in any offices